SectorBiological Technology
Established Date--
Listing Date07/02/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees103
Fiscal Year Ends31/12
Security TypeCommon stock
Office address131 Oyster Point Blvd, Suite 600 , South San Francisco, California 94080
Business
IntroductionAlector, Inc., originally incorporated as a limited liability company in Delaware in May 2013, is a clinical-stage biopharmaceutical company. Groundbreaking immuno-neurology, a new treatment for neurodegeneration. Immunoneurology identifies immune dysfunction as the underlying cause of a variety of pathologies that are drivers of degenerative encephalopathy. They are developing therapies designed to counteract these conditions at the same time by restoring healthy immune function to the brain.
